Intra-articular hyaluronic acid preparations for use in the treatment of osteoarthritis

International Journal of Evidence-Based Healthcare

Volumn 9, Issue 3, 2011, Pages 261-264

  McNeil, Julian David ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Evidence based practice; Rheumatology

Indexed keywords

DRUG DERIVATIVE; HYALURONIC ACID; VISCOELASTIC SUBSTANCE;

ARTICLE; HUMAN; INTRAARTICULAR DRUG ADMINISTRATION; KNEE OSTEOARTHRITIS; METABOLISM; OSTEOARTHRITIS; SYNOVIAL FLUID;

HUMANS; HYALURONIC ACID; INJECTIONS, INTRA-ARTICULAR; OSTEOARTHRITIS; OSTEOARTHRITIS, KNEE; SYNOVIAL FLUID; VISCOELASTIC SUBSTANCES;

EID: 84855181704     PISSN: 17441595     EISSN: 17441609     Source Type: Journal    
DOI: 10.1111/j.1744-1609.2011.00216.x     Document Type: Note

References (28)

1. Felson D. Osteoarthritis of the knee. N Engl J Med 2008; 354: 841-8.
2. Balazs E, Denlinger J. Clinical uses of hyaluronan. In: Evered D, Whenlen J, eds. The Biology of Hyaluronan. Ciba Foundation Symposium No 43. Chichester, NY: John Wiley, 1989; 265- 80.
3. Balazs E, Denlinger J. Viscosupplementation: a new concept in the treatment of osteoarthritis. J Rheumatol Supp 1993; 39: 3-9.
4. Wang C, Lin J, Chang C, Lin Y, Hou S. Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. J Bone Joint Surg 2004; 86: 538-45.
5. Chevalier X, Jerosch J, Goupille P et al. Single intra-articular treatment with 6 ml Hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial. Ann Rhem Dis 2010; 69: 113-19.
6. Bannuru R, Natov N, Obadan I, Price L, Schmid C, McAlindon T. Therapeutic trajectory of hyaluronic acid versus corticosteroids in the treatment of knee osteoarthritis: a systematic review and meta-analysis. Arthritis Rheum 2009; 61: 1704-11.
7. Watanabe K, Yamaguchi Y. Molecular identification of putative human hyaluronan synthetase. J Biol Chem 1996; 271: 22945- 8.
8. McNeil J, Wiebkin O, Betts W, Cleland L. Depolymerization products of hyaluronic acid after exposure to oxygen derived free radicals. Ann Rheum Dis 1985; 44: 780-9.
9. Gleghorn J, Jones A, Flannery C, Bonassar L. Boundary mode lubrication of articular cartilage by recombinant human lubricin. J Orth Res 2009; 27: 771-7.
10. Tamoto K, Tada M, Shimada S et al. Effects of high molecular weight hyaluronate on the functions of guinea pig polymorphonuclear leucocytes. Semin Arthritis Rheum 1993; 22 (6 Suppl. 1): 4-8.
11. Culty M, Nguyen H, Underhill C. The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronate. J Cell Biol 1992; 116: 1055-62.
12. Laurent T, Laurent U, Fraser J. Functions of hyaluronan. Ann Rheum Dis 1995; 54: 429-32.
13. Frampton J. Hylan G-F 20 Single-Injection Formulation. Drugs Aging 2010; 27: 77-85.
14. Lo G, LaValley M, McAlindon T, Felson D. Intra-articular hyaluronic acid in treatment of knee osteoarthritis: a meta-analysis. JAMA 2003; 290: 3115-21.
15. Ballamy N, Campbell J, Welch V, Gee T, Bourne R, Wells G. Viscosupplementation for the treatment of osteoarthritis of the knee (Review). Cochrane Database Syst Rev 2005; (2): CD005321.
16. Modawal A, Ferrer M, Choi H, Castle J. Hyaluronic Acid Injections relieve knee pain. J Fam Pract 2005; 54: 758-67.
17. Arrich J, Piribauer F, Mad P, Schmid D, Klaushofer K, Mullner M. Intra-articular hyaluronic acid for the treatment of osteoarthritis of the knee: systematic review and meta-analysis. CMAJ 2005; 172: 1039-1043.
18. Medina J, Thomas A, Denegar C. Knee osteoarthritis: should your patient opt for hyaluronic acid injection? J Fam Pract 2006; 55: 669-75.
19. Reichenbach S, Blank S, Rutjes A et al. Hylan versus hyaluronic acid for osteoarthritis of the knee: a systematic review and meta-analysis. Arthritis Rheum 2007; 15: 1410-18.
20. Bagga H, Burkhardt D, Sambrook P, March L. Longterm effects of intra-articular hyaluronan on synovial fluid in osteoarthritis of the knee. J Rheumatol 2006; 33: 946-50.
21. Fukuda K, Dan H, Takayama M, Kumano F, Saitoh M, Tanaka S. Hyaluronic acid increases proteoglycan synthesis in bovine articular cartilage in the presence of IL-1. J Pharm Exp Therapeutics 1996; 277: 1672-5.
22. Takahashi K, Goomer R, Harwood F, Kubo T, Hirasawa T, Amiel Y. The effects of hyaluronan on matrix metalloproteinase-3, interleukin-1bate and tissue inhibitor of metalloproteinases gene expression during the development of osteoarthritis. Osteoarthr Cartil 1999; 7: 182-90.
23. Cubukcu D, Ardic F, Karabulut N, Topuz O. Hylan GF-20 efficacy on articular cartilage quality in patients with knee osteoarthritis: clinical and MRI assessment. Clin Rheumatol 2005; 24: 336- 41.
24. Gomis A, Pawlak M, Balazs E, Schmidt R, Belmonte C. Effects of different molecular weight elastoviscous hyaluronan solutions on articular nociceptive afferents. Arthritis Rheum 2004; 50: 314-26.
25. Conrozier T, Bertin P, Baileul F et al. Clinical response to intraarticular injections of hylan GF20 in symptomatic hip osteoarthritis: the OMERACT-OARSI criteria applied to the results of a pilot study. Joint Bone Spine 2006; 73: 705-9.
26. DePalma M, Ketchum J, Queler E, Trussell B. Prospective pilot study of painful lumbar facet joint arthropathy after intraarticular injection of Hylan G-F 20. PM&R 2009; 1: 908-15.
27. Munteanu S, Menz H, Zammit G et al. Efficacy of intra-articular hyaluronan (Synvisc) for the treatment of osteoarthritis affecting the first metatarsophalangeal joint of the foot (Hallux limitus): study protocol for a randomised placebo controlled trial. J Foot Ankle Res 2009; 2: 2.
28. Mukherjee D, Nissen S, Topol E. Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA 2001; 286: 954-9.